Fulgent Genetics, Inc.
FLGTFulgent Genetics is a technology-driven precision medicine company that operates a large-scale laboratory services business and a therapeutic development division.
Earnings
Next report
Nov 5, 2026 (In 3 days)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Fulgent Genetics is a technology-driven precision medicine company that operates a large-scale laboratory services business and a therapeutic development division. The company provides a comprehensive menu of genetic and diagnostic tests designed for clinical, biopharmaceutical, and consumer use. Additionally, it leverages a proprietary nanoencapsulation platform to develop targeted drug candidates for the treatment of various cancers.
A technology-focused provider of genetic testing that differentiates through a proprietary software platform and a dual-track strategy of diagnostics and drug development.
FAQ
- What is Fulgent Genetics, Inc.'s market cap?
- Fulgent Genetics, Inc. (FLGT) has a market capitalization of $596.5M and trades on NASDAQ.
- What is Fulgent Genetics, Inc.'s revenue and profitability?
- Fulgent Genetics, Inc. generated $323.9M in trailing twelve-month revenue with a net loss of $84.4M, representing a net margin of -26.0%. Gross margin stands at 35.6%, with free cash flow of -$108.8M. The latest reported period is Q2 2026.
- Who are Fulgent Genetics, Inc.'s competitors?
- Fulgent Genetics, Inc.'s key competitors include Myriad Genetics, Inc., GeneDx Holdings Corp., NeoGenomics, Inc., and others. These companies compete in similar markets and product categories.
- Who does Fulgent Genetics, Inc. partner with?
- Fulgent Genetics, Inc.'s notable partners include Illumina Inc., Roche Holdings AG, Leica Biosystems, and others.
- What subsidiaries does Fulgent Genetics, Inc. have?
- Fulgent Genetics, Inc.'s subsidiaries include Fulgent Pharma Holdings, Inc., ANP Technologies, Inc., Fulgent Therapeutics LLC.
- Where is Fulgent Genetics, Inc. headquartered?
- Fulgent Genetics, Inc. is headquartered in United States of America and employs approximately 1,012 people. It has been publicly traded since 2016.
